Form 4: Guardant Health: Executive Equity Vesting and Tax Withholding

Guardant Health's Chief Medical Officer, Craig Eagle, reported on April 1, 2026, regarding the vesting of restricted stock units and associated tax withholding.

Summary

• Craig Eagle, Chief Medical Officer of Guardant Health, Inc., reported transactions on April 1, 2026, related to the vesting of restricted stock units (RSUs).
• A total of 15,399 shares of common stock were acquired through the vesting of RSUs.
• Of these, 5,779 shares were retained by the company to cover tax withholding obligations, valued at $91.15 per share.
• Following these transactions, Mr. Eagle beneficially owns 72,001 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine equity vesting and tax withholding for an executive, with no significant positive or negative financial implications presented.

Positives

• Vesting of restricted stock units indicates continued equity compensation for key management.
• The retention of shares for tax withholding is a standard procedure and suggests no unexpected tax liabilities for the executive.

Negatives

• The retention of shares for tax withholding represents a reduction in the net shares received by the executive.

Risks

• The filing does not explicitly mention any risks.
• Potential future tax implications for the executive related to equity compensation are not detailed.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Management Comments

• The retention of shares was not in excess of the amount of the tax liability.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for public company executives regarding their equity transactions. These filings provide transparency into insider holdings and compensation structures, which are standard practices in the biotechnology and healthcare sectors where Guardant Health operates.

Stakeholder Impact

• Shareholders: Increased transparency into executive compensation and potential dilution from equity awards.
• Employees: Reinforces the company's use of equity as a compensation tool for key personnel.
• Management: Standard reporting of equity compensation and tax obligations.

Next Steps

• Continued vesting of remaining restricted stock units as per the award agreements.
• Ongoing reporting of any future equity transactions by Mr. Eagle.

Key Dates

Keywords

Guardant Health, GH, Form 4, SEC Filing, Insider Trading, Stock Options, Restricted Stock Units, Equity Compensation, Tax Withholding, Craig Eagle, Chief Medical Officer